SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001558370-22-002714
Filing Date
2022-03-03
Accepted
2022-03-03 07:00:53
Documents
7
Effectiveness Date
2022-03-03

Document Format Files

Seq Description Document Type Size
1 POSASR tmb-20220303xposasr.htm POSASR 622486
2 EX-5.1 tmb-20220303xex5d1.htm EX-5.1 44901
3 EX-23.1 tmb-20220303xex23d1.htm EX-23.1 3687
4 EX-FILING FEES tmb-20220303xexfilingfees.htm EX-FILING FEES 71731
5 GRAPHIC tmb-20220303xposasr005.jpg GRAPHIC 5142
6 GRAPHIC tmb-20220303xposasr004.jpg GRAPHIC 14934
7 GRAPHIC tmb-20220303xex5d1001.jpg GRAPHIC 14526
  Complete submission text file 0001558370-22-002714.txt   792007
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-253955 | Film No.: 22706708
SIC: 2836 Biological Products, (No Diagnostic Substances)